XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share based Compensation (Tables)
3 Months Ended
Mar. 31, 2018
Stockholders' Equity  
Schedule of fair value weighted-average assumptions

 

 

Three Months
Ended March 31,

 

 

 

2018

 

2017

 

Expected stock price volatility

 

81.2

%

83.2

%

Risk free interest rate

 

2.3

%

2.1

%

Expected life of options (years)

 

5.62

 

6.25

 

Expected annual dividend per share

 

$

0.00

 

$

0.00

 

 

Summary of stock options outstanding

 

 

Number of
Shares

 

Weighted
Average
Exercise Price

 

Weighted
Average
Remaining
Contractual Life

 

Aggregate
Intrinsic
Value

 

 

 

(in thousands)

 

 

 

 

 

(in millions)

 

Options outstanding, December 31, 2017

 

15,181.1

 

$

7.48

 

 

 

 

 

Granted

 

1,611.5

 

$

15.54

 

 

 

 

 

Exercised

 

(562.2

)

$

7.08

 

 

 

 

 

Forfeited

 

(48.8

)

$

7.43

 

 

 

 

 

Expired

 

(4.8

)

$

9.03

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding, March 31, 2018

 

16,176.8

 

$

8.30

 

7.4 years

 

$

110.6

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and unvested expected to vest, March 31, 2018

 

15,363.0

 

$

8.15

 

7.2 years

 

$

105.7

 

Exercisable at March 31, 2018

 

8,648.3

 

$

6.97

 

6.2 years

 

$

70.1

 

 

Summary of non-vested Restricted Stock Units activity

 

 

Number of Share (in
thousands)

 

Weighted 
Average Grant Date 
Fair Value

 

Weighted Average 
Remaining Years

 

Aggregate 
Intrinsic Value 
(in millions)

 

Non-vested units as of December 31, 2017

 

2,575.1

 

$

5.85

 

 

 

 

 

Granted

 

1,335.1

 

$

16.99

 

 

 

 

 

Vested

 

(353.4

)

$

5.26

 

 

 

 

 

Forfeited

 

(16.1

)

$

5.93

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested units as of March 31, 2018

 

3,540.7

 

$

10.11

 

3.0 years

 

$

53.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Summary of the equity-based compensation expense recognized in the statements of operations

 

 

Three Months Ended
March 31,

 

(in thousands):

 

2018

 

2017

 

Equity compensation expense recognized in:

 

 

 

Research and development expense

 

$

3,057

 

$

2,753

 

Selling, general and administrative expense

 

4,421

 

3,277

 

 

 

 

 

 

 

Total equity compensation expense

 

$

7,478

 

$

6,030